Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIRF-C in acute cholecystitis
NCT02070627Phase 1Completed
- Sponsor
- The Ohio State University
- Start
- Jul 2013
- Primary completion
- Aug 2014
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by The Ohio State University. Primary endpoints: Adverse events related to use of indocyanine green (ICG) at 2 weeks, Anatomic identification with NIRF-C and IOC and 1 more. Started Jul 2013; status: completed.
Beyond the preview
Go deeper on NCT02070627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02070627.